Breaking News

Herbalife Tops Wall Street Estimates

April 29, 2013

To hell with all the naysayers and pyramid-scheme antagonists. Herbalife topped Wall Street's profit target for the 17th consecutive quarter.

The nutritional products seller reported a first-quarter profit of $118.8 million, or $1.10 a share, up from $108.1 million, or 88 cents a share, in the year-earlier period. Revenue rose 17% to $1.1 billion.

Moreover, Herbalife raised its 2013 profit target to between $4.60 a share and $4.80 a share, up from $4.45 and $4.65 a share. The company also raised its forecast for sales and volume point growth. However, Herbalife's second quarter forecast for a profit of $1.14 a share to $1.18 a share is below the $1.26 a share analysts were looking for.

In after-hours trade, Herbalife's stock dipped to $38.70 after posting a gain just after the report came out. Herbalife's stock has become a battleground stock for high-profile hedge fund managers. Bill Ackman has made a $1 billion short bet against the stock, while Carl Icahn has taken a huge stake in the company.

Related End-User Markets:

  • Patent Activity: Colgate-Palmolive

    Patent Activity: Colgate-Palmolive

    December 6, 2016
    New oral care compositions, the use of radish root ferment filtrate in a cleanser and more.

  • Cos Bar: Turning 40 and Hitting Fast Forward

    Cos Bar: Turning 40 and Hitting Fast Forward

    Christine Esposito, Associate Editor||November 21, 2016
    With a recent investor infusion, a new CEO and rebranding effort underway, this luxury beauty retailer has big plans.

  • Organic Matter

    Organic Matter

    Christine Esposito, Associate Editor||November 14, 2016
    FTC and USDA hold a public roundtable to discuss consumers’ perception of organic claims.

  • The World Comes to Orlando

    The World Comes to Orlando

    Tom Branna, Editorial Director||December 1, 2016
    More than 1,600 chemists traveled to Florida for the IFSCC Congress

  • Perform or Perish

    Perform or Perish

    Christine Esposito, Associate Editor||December 1, 2016
    Success in today’s skin care sector begins with active ingredients, formulated in products that address modern-day issues.

  • Soap Opera

    Soap Opera

    Christine Esposito, Associate Editor||November 2, 2016
    FDA’s recent antibacterial ruling has soap sector stakeholders scrambling to keep some ingredients in their formulation kit.